We are live on ! Find out more
PA

Pinnacle Associates Portfolio holdings

AUM $7.78B
1-Year Est. Return 45.07%
This Fund
S&P 500
This Quarter Est. Return
+10.13%
1 Year Est. Return
+45.07%
3 Year Est. Return
+102.47%
5 Year Est. Return
+115.95%
10 Year Est. Return
+586.2%
AUM
$5.12B
AUM Growth
+$288M
Cap. Flow
-$136M
Cap. Flow %
-2.66%
Top 10 Hldgs %
21.33%
Holding
608
New
37
Increased
185
Reduced
325
Closed
15

Sector Composition

Rank Sector Weight
1 Industrials 16.77%
2 Technology 12.51%
3 Healthcare 12.2%
4 Communication Services 11.01%
5 Consumer Discretionary 7.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
REGN icon
1
Regeneron Pharmaceuticals
REGN
$69.9B
$155M 3.03%
563,500
-44,118
-7% -$12.7M
PCP
2
DELISTED
PRECISION CASTPARTS CORP
PCP
$132M 2.58%
491,524
-11,509
-2% -$2.89M
LVS icon
3
Las Vegas Sands
LVS
$31.6B
$123M 2.41%
1,564,748
-54,662
-3% -$3.93M
DISCK
4
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$112M 2.19%
2,677,638
-77,740
-3% -$3.04M
RCL icon
5
Royal Caribbean
RCL
$81.8B
$107M 2.09%
2,252,386
-59,968
-3% -$2.54M
CMI icon
6
Cummins
CMI
$91.3B
$105M 2.06%
746,746
-19,365
-3% -$2.57M
LRCX icon
7
Lam Research
LRCX
$365B
$92.6M 1.81%
17,003,960
-439,240
-3% -$2.31M
TGNA
8
DELISTED
TEGNA Inc
TGNA
$91.3M 1.78%
5,900,957
-127,504
-2% -$1.8M
PLL
9
DELISTED
PALL CORP
PLL
$86.8M 1.7%
1,017,181
-24,399
-2% -$1.98M
TRMB icon
10
Trimble
TRMB
$13B
$86.6M 1.69%
2,494,755
-66,223
-3% -$2.09M
FWLT
11
DELISTED
FOSTER WHEELER AG (SWITZERLAND)
FWLT
$80.9M 1.58%
2,451,027
-63,565
-3% -$1.86M
IONS icon
12
Ionis Pharmaceuticals
IONS
$9.25B
$80.3M 1.57%
2,016,369
-48,391
-2% -$1.72M
SBGI icon
13
Sinclair Inc
SBGI
$974M
$79.7M 1.56%
2,231,703
-58,966
-3% -$1.98M
ATML
14
DELISTED
ATMEL CORP
ATML
$72.3M 1.41%
9,228,621
+1,234,847
+15% +$9.04M
KSU
15
DELISTED
Kansas City Southern
KSU
$71.1M 1.39%
573,955
-15,418
-3% -$1.85M
BEL
16
DELISTED
Belmond Ltd.
BEL
$69.9M 1.37%
4,626,926
-127,766
-3% -$1.82M
VAL
17
DELISTED
Valspar
VAL
$65.1M 1.27%
913,227
-24,085
-3% -$1.67M
HP icon
18
Helmerich & Payne
HP
$3.36B
$64.8M 1.27%
770,721
-16,348
-2% -$1.27M
LSI
19
DELISTED
LSI CORPORATION
LSI
$60.3M 1.18%
5,462,565
-128,909
-2% -$1.1M
SGEN
20
DELISTED
Seagen Inc. Common Stock
SGEN
$59.3M 1.16%
1,486,373
-35,015
-2% -$1.43M
HXL icon
21
Hexcel
HXL
$8.28B
$57.1M 1.12%
1,277,982
-36,853
-3% -$1.56M
ARRS
22
DELISTED
ARRIS International plc Ordinary Shares
ARRS
$55.6M 1.09%
2,283,190
-58,546
-3% -$1.12M
WDR
23
DELISTED
Waddell & Reed Financial, Inc.
WDR
$52.8M 1.03%
811,337
-21,258
-3% -$1.3M
BID
24
DELISTED
Sotheby's
BID
$52.8M 1.03%
992,314
-25,834
-3% -$1.33M
CCJ icon
25
Cameco
CCJ
$38.9B
$51.4M 1%
2,475,803
-60,366
-2% -$1.17M

Similar funds

Pinnacle Associates's Q4 2013 Portfolio in Review

As of Q4 2013, Pinnacle Associates held 608 positions worth $5.12B, up 6% from $4.83B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Pinnacle Associates's Q4 2013 filing shows 37 new, 185 increased, 325 reduced and 15 closed positions. Its largest new stake was FAIRWAY GROUP HLDGS CORP CL A COM STK (DE): 1,273,770 shares worth $23.1M. The largest sale was ONYX PHARMACEUTICALS INC, an estimated $90.6M.

By sector, the portfolio is most concentrated in Industrials at 17% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

  • Pinnacle Associates's largest Q4 2013 buy was FAIRWAY GROUP HLDGS CORP CL A COM STK (DE): 1,273,770 shares worth $23.1M.
  • Pinnacle Associates added most to Madison Square Garden in Q4 2013, an estimated $11.5M increase.
  • Pinnacle Associates's biggest Q4 2013 reduction was Regeneron Pharmaceuticals, cutting an estimated $12.7M.
  • Pinnacle Associates fully exited ONYX PHARMACEUTICALS INC in Q4 2013, selling an estimated $90.6M.
  • Pinnacle Associates's ten largest holdings make up 21% of its $5.12B portfolio in Q4 2013.
  • Pinnacle Associates opened 37 new positions and closed 15 in Q4 2013.
  • Pinnacle Associates's portfolio value rose 6% quarter-over-quarter to $5.12B.

Based on Pinnacle Associates's 13F filing for Q4 2013, filed 12 Feb 2014.